Q Fever Deutsch

[Marylynn]

Beforethe rubella vaccine, epidemics happened every 6-9 years, usually among kids 5 to 9 years old, along with many cases of congenital rubella. Thanks to immunization, there are far fewer cases of rubella and congenital rubella.

The rubella rash is often the first sign of illness that a parent notices. It can look like many other viral rashes, appearing as either pink or light red spots, which may merge to form evenly colored patches. The rash can itch and lasts up to 3 days. As the rash clears, the affected skin might shed in very fine flakes.

Other symptoms of rubella, which are more common in teens and adults, can include headache, loss of appetite, mild conjunctivitis (inflammation of the lining of the eyelids and eyeballs), a stuffy or runny nose, swollen document.write(def_lymphnodes_T); lymph nodesin other parts of the body, and pain and swollen joints. Many people with rubella have few or no symptoms.

The rubella rash usually lasts 3 days. Lymph nodes may be swollen for a week or more, and joint pain can last for more than 2 weeks. Children who have rubella usually recover within 1 week, but adults may take longer.

Rubella is contagious, and passes from person to person through tiny drops of fluid from the nose and throat through sneezing and coughing. Someone also can get it by sharing food or drink with a person who's infected. People who have rubella are most contagious from 1 week before to 1 week after the rash appears. Someone who is infected but has no symptoms can still spread the virus.

The virus also can pass through a pregnant woman's bloodstream to infect her unborn child. Babies born with congenital rubella syndrome are at risk for serious problems with their growth, thinking, heart and eyes, hearing, and liver, spleen, and bone marrow. They also can shed the virus in their urine (pee) and fluid from their nose and throat for a year or more, so can pass the virus to people who aren't immunized against it.

The rubella vaccine protects people from the disease. Widespread immunization is the key to preventing the spread of the virus and protecting babies from the serious health problems of congenital rubella syndrome.

Most rubella infections today are in young, non-immunized adults rather than in kids. In fact, experts say that about 10% of young adults are not vaccinated against rubella, which could be dangerous for any children they might have someday.

The rubella vaccine should not be given to pregnant women or to a woman who plans to become pregnant within 1 month of getting it. If you are thinking about becoming pregnant, make sure that you're immune to rubella through a blood test or proof of immunization. If you're not immune, get the vaccine at least 1 month before you become pregnant.

Antibiotics can't treat rubella because they only work against bacteria, not viruses. Unless it causes other problems, rubella will get better on its own. Rubella usually is mild in kids, who often can be cared for at home. Check your child's temperature and call the doctor if the fever climbs too high.

To ease minor discomfort, you can give your child acetaminophen or ibuprofen. Never give aspirin to a child who has a viral illness, as such use is linked to a serious condition called Reye syndrome.

Note: All information on Nemours KidsHealth is for educational purposes only. For specific medical advice, diagnoses, and treatment, consult your doctor. 1995-2024. The Nemours Foundation. Nemours Children's Health, KidsHealth, and Well Beyond Medicine are registered trademarks of The Nemours Foundation. All rights reserved. Images sourced by The Nemours Foundation and Getty Images.

Rubella is a highly contagious viral disease characterized by slight fever, mild rash and swollen glands. Although most cases are mild, if rubella is contracted early in pregnancy, it can spread from the mother to her developing baby through the bloodstream and result in birth defects and/or fetal death. As a result of widespread immunization, rubella does not circulate in the United States, but can be contracted through foreign travel.

The number of cases of rubella decreased dramatically in the United States following the introduction of the rubella vaccine in 1969. The decrease was greatest among children. Adults account for an increasing proportion of the few cases that still occur in United States. These are often individuals who remain unvaccinated for religious reasons or are foreign-born immigrants who come from areas where rubella vaccine is not routinely used. Rubella still remains a common disease in many parts of the world and the risk of exposure to rubella outside of the United States is high. Travelers to countries where rubella cases still occur should be immune to rubella.

Rubella is spread by direct contact with nasal or throat secretions of infected individuals. Rubella can also be transmitted by breathing in droplets that are sprayed into the air when an infected person sneezes, coughs or talks.

Rubella is a mild illness which may present few or no symptoms. Symptoms may include a rash, slight fever, joint aches, headache, discomfort, runny nose, sore throat and reddened eyes. The lymph nodes just behind the ears and at the back of the neck may swell, causing some soreness and/or pain. The rash, which may be itchy, first appears on the face and progresses from head to foot, lasting about three days. As many as half of all rubella cases occur without a rash.

Complications occur more frequently in adult women, who may experience arthritis or arthralgia, often affecting the fingers, wrists and knees. These joint symptoms rarely last for more than a month after appearance of the rash.

Rubella vaccine is given in combination measles, mumps, rubella (MMR) vaccine and is recommended for anyone born on or after January 1, 1957 who does not have laboratory evidence of rubella immunity. Birth before 1957 is not acceptable evidence of rubella immunity for women who could become pregnant; women of childbearing age should have their immunity checked and receive rubella vaccine if needed.

Although only one dose of rubella-containing vaccine is required as acceptable evidence of immunity to rubella, children should receive two doses of MMR vaccine. Rubella vaccine is first given on or after a child's first birthday as MMR vaccine. Children usually receive the first dose between 12 and 15 months of age and the second dose prior to school entry at four to six years of age.

In New York State, rubella vaccine is required of all children enrolled in all pre-kindergarten programs and schools. Healthcare personnel and college students are also required to demonstrate immunity against rubella.

Rubella infection is dangerous because of its ability to damage an unborn baby. If rubella immunization was discontinued, immunity to rubella would decline and rubella disease would return. The danger would be to pregnant women who, if infected, could pass the disease to their infants (fetuses) causing CRS.

Maintaining high levels of rubella immunization in the community is critical to controlling the spread. Control of the spread of rubella is needed primarily to prevent the birth defects caused by CRS. Therefore, women of childbearing age should have their immunity checked and receive rubella vaccine if needed. Infected individuals should be excluded from work or school during their infectious period.

Congenital rubella syndrome occurs among at least 25 percent of infants born to women who had rubella during the first three months of pregnancy. Infection of a pregnant woman can result in a miscarriage, stillbirth or the birth of an infant with abnormalities which may include deafness, blindness, cataracts, heart defects, mental retardation, liver and spleen damage.

Rubella is a contagious disease caused by a virus. It is also called German measles, but it is caused by a different virus than measles. Most people who get rubella usually have mild illness, with symptoms that can include a low-grade fever, sore throat, and a rash that starts on the face and spreads to the rest of the body. Some people may also have a headache, pink eye, and general discomfort before the rash appears. Rubella can cause a miscarriage or serious birth defects in an unborn baby if a woman is infected while she is pregnant.

Rubella can be prevented with MMR vaccine. This protects against three diseases: measles, mumps, and rubella. CDC recommends children get two doses of MMR vaccine, starting with the first dose at 12 through 15 months of age, and the second dose at 4 through 6 years of age. Teens and adults also should also be up to date on their MMR vaccination.

Children may also get MMRV vaccine, which protects against measles, mumps, rubella, and varicella (chickenpox). This vaccine is only licensed for use in children who are 12 months through 12 years of age.

Before the availability of rubella vaccines in the United States, rubella was a common disease that occurred primarily among young children. The last major epidemic in the United States occurred during 1964 to 1965, when there was an estimated 12.5 million rubella cases in the United States. Because of successful vaccination programs, rubella has been eliminated from the United States since 2004. However, rubella is still common in other countries. Unvaccinated people can get rubella while abroad and bring the disease to the United States and spread it to others.

Q fever is a zoonotic disease caused by the bacterium Coxiella burnetii. Inhalation of contaminated dust particles or aerosols originating from animals (esp. small ruminants) is the main source of human infection. Hence, an active early warning system for Q fever in German small ruminant livestock was conceptualized to prevent human infections. First, we describe the best practice for establishing this system before evaluating its feasibility, as the combination of both evokes conflicts. Vaginal swabs from all husbandry systems with a focus on reproductive females should pooled and investigated by PCR to detect C. burnetii-shedding animals. Multistage risk-based sampling shall be carried out at the flock level and within-flock level. At the flock level, all flocks that are at risk to transmit the pathogen to the public must be sampled. At the within-flock level, all primi- and multiparous females after lambing must be tested in order to increase the probability of identifying a positive herd. Sampling should be performed during the main lambing period and before migration in residential areas. Furthermore, individual animals should be tested before migration or exhibition to ensure a negative status. If a flock tests positive in at least one individual sample, then flock-specific preventive measures should be implemented. This approach implies huge financial costs (sample testing, action/control measures). Hence, taking the step to develop more feasible and affordable preventive measures, e.g., vaccinating small ruminant flocks, should replace testing wherever justifiable.

3a8082e126